Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192412 | SCV000247223 | likely benign | not specified | 2016-10-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000236144 | SCV000292890 | likely pathogenic | not provided | 2016-10-31 | criteria provided, single submitter | clinical testing | The E2640K variant in the DYNC1H1 gene has not been published as pathogenic, nor has it been reported as a benign polymorphism to our knowledge. The E2640K variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The E2640K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. The E2640K variant is a strong candidate for a disease-causing variant |
Mayo Clinic Genetic Testing Laboratories, |
RCV000660532 | SCV000782635 | uncertain significance | Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2O; Mental retardation, autosomal dominant 13 | 2017-03-23 | criteria provided, single submitter | clinical testing |